The company combines microfluidics, biochemistry, photonics, and information technology to build high-performance point-of-care diagnostics devices. Their system is being developed for a broad menu of clinical applications, including multiplexed assays of proteins, nucleic acids, and peptides. Their first clinical applications are in the screening, diagnostics, and monitoring of cardiovascular disease and infectious disease. They highly value collaboration, prioritize the needs of customers, and rapidly deliver solutions. The company is based in Neuchatel, Switzerland, and Boston, United States, and is supported by some of the most highly regarded experts in the field of biosensors.